KEYNOTE-905: A phase III study of cystectomy plus perioperative pembrolizumab versus cystectomy alone in cisplatin (cis)-ineligible patients (pts) with muscle-invasive bladder cancer (MIBC)

被引：0
|
作者：
Galsky, M. [1 ]
Necchi, A. [2 ]
Shore, N. D. [3 ]
Witjes, F. [4 ]
Nam, K. [5 ]
Godwin, J. L. [5 ]
Frenkl, T. L. [5 ]
Plimack, E. R. [6 ]
机构：
[1] Mt Sinai Hosp, Icahn Sch Med, Tisch Canc Inst, New York, NY 10029 USA
[2] Fdn IRCCS Ist Nazl Tumori, Med Oncol, Milan, Italy
[3] Carolina Urol Res Ctr, Med Oncol, Myrtle Beach, SC USA
[4] Radboudumc, Urol, Nijmegen, Netherlands
[5] Merck & Co Inc, Med Oncol, Kenilworth, NJ USA
[6] Fox Chase Canc Ctr, Hematol Oncol, 7701 Burholme Ave, Philadelphia, PA 19111 USA
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
989TiP
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Neoadjuvant cohort study in muscle-invasive bladder cancer (MIBC) before cystectomy
    不详
    UROLOGIE, 2024, 63 (07): : 746 - 747
  • [22] Perioperative Therapy of muscle-invasive Bladder Cancer for Cisplatin ineligible Patients A randomised Phase III Study of neoadjuvant and adjuvant Nivolumab plus NKTR-214 versus Nivolumab Monotherapy versus Standard of Care for Cisplatin ineligible Patients with muscle-invasive (CheckMate-009) Bladder Cancer (MIBC) - AUO AB 73/20
    Rexer, H.
    Grimm, M. -O.
    Ohlmann, C. -H.
    UROLOGE, 2021, 60 (08): : 1105 - 1106
  • [23] Perioperative enfortumab vedotin (EV) plus pembrolizumab (pembro) versus chemotherapy in cisplatin-eligible patients (pts) with muscle-invasive bladder cancer (MIBC): Phase 3 KEYNOTE-B15/EV-304.
    Hoimes, Christopher J.
    Loriot, Yohann
    Bedke, Jens
    Nishiyama, Hiroyuki
    Kataria, Ritesh S.
    Moreno, Blanca Homet
    Galsky, Matt D.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [24] KEYNOTE-B15/EV-304: Randomized phase 3 study of perioperative enfortumab vedotin plus pembrolizumab versus chemotherapy in cisplatin-eligible patients with muscle-invasive bladder cancer (MIBC).
    Hoimes, Christopher J.
    Bedke, Jens
    Loriot, Yohann
    Nishiyama, Hiroyuki
    Fang, Xiao
    Kataria, Ritesh S.
    Moreno, Blanca Homet
    Galsky, Matt D.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [25] Phase II Study of Gemcitabine and Split-Dose Cisplatin Plus Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Bladder Cancer
    Rose, Tracy L.
    Harrison, Michael R.
    Deal, Allison M.
    Ramalingam, Sundhar
    Whang, Young E.
    Brower, Blaine
    Dunn, Mary
    Osterman, Chelsea K.
    Heiling, Hillary M.
    Bjurlin, Marc A.
    Smith, Angela B.
    Nielsen, Matthew E.
    Tan, Hung-Jui
    Wallen, Eric
    Woods, Michael E.
    George, Daniel
    Zhang, Tian
    Drier, Anthony
    Kim, William Y.
    Milowsky, Matthew I.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (28) : 3140 - +
  • [26] LOCAL-CONTROL OF MUSCLE-INVASIVE BLADDER-CANCER - PREOPERATIVE RADIOTHERAPY AND CYSTECTOMY VERSUS CYSTECTOMY ALONE
    COLE, CJ
    POLLACK, A
    ZAGARS, GK
    DINNEY, CP
    SWANSON, DA
    VONESCHENBACH, AC
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1995, 32 (02): : 331 - 340
  • [27] Adjuvant chemotherapy (AC) with cisplatin plus gemcitabine (CG) versus chemotherapy (CT) at relapse (CR) in patients (pts) with muscle-invasive bladder cancer (MIBC) submitted to radical cystectomy (RC). An Italian multicenter randomised phase III trial
    Cognetti, F.
    Ruggeri, E. M.
    Felici, A.
    Gallucci, M.
    Muto, G.
    Pollera, C. F.
    Massidda, B.
    Rubagotti, A.
    Giannarelli, D.
    Boccardo, F.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [28] Can neoadjuvant gemcitabine plus carboplatin followed by immediate cystectomy improve survival in patients with cisplatin-ineligible muscle-invasive bladder cancer?
    Koie, Takuya
    Suzuki, Yuichiro
    Tobisawa, Yuki
    Yoneyama, Tohru
    Mori, Kazuyuki
    Okamoto, Akiko
    Yamamoto, Hayato
    Imai, Atsushi
    Hatakeyama, Shingo
    Yoneyama, Takahiro
    Hashimoto, Yasuhiro
    Ohyama, Chikara
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [29] Re: Phase II Study of Gemcitabine and Split-dose Cisplatin plus Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients with Muscle-invasive Bladder Cancer
    Laukhtina, Ekaterina
    Shariat, Shahrokh F.
    EUROPEAN UROLOGY, 2022, 82 (02) : 242 - 243
  • [30] Bladder preservation in adult patients with muscle-invasive bladder cancer (MIBC) who are not candidates for or refuse radical cystectomy
    Rexer, H.
    Niegisch, G.
    Merseburger, A.
    UROLOGIE, 2024, 63 (04): : 424 - 425
12345